Gilead

Gilead to buy Kite Pharma for about $11 billion – MarketWatch
news.google.com

Los Angeles Times Gilead to buy Kite Pharma for about $11 billionMarketWatchGilead Sciences Inc. has agreed to pay about $11 billion for Kite Pharma Inc. and its promising new technology for harnessing the body's immune system to fight cancer. Gilead will pay $180 a share, representing a 29% premium over Kite's closing price …Gilead to buy […]

163
Like
Save